Bill Sponsor
House Bill 6875
116th Congress(2019-2020)
To direct the Comptroller General of the United States to conduct a study to investigate the feasibility of establishing user fees to offset certain Federal costs attributable to the procurement of single-source materials for the Strategic National Stockpile, and for other purposes.
Introduced
Introduced
Introduced in House on May 14, 2020
Overview
Text
Introduced
May 14, 2020
Latest Action
May 14, 2020
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
6875
Congress
116
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Sponsorship by Party
Democrat
Michigan
Democrat
California
Democrat
Connecticut
Democrat
District of Columbia
Republican
New Jersey
House Votes (0)
Senate Votes (0)
No House votes have been held for this bill.
Summary

This bill requires the Government Accountability Office to study the feasibility of assessing user fees to offset federal costs associated with single-source materials for which the Strategic National Stockpile is the sole provider (e.g., certain antitoxins).

The study must address whether health care providers or other entities that receive such materials generate profits when charging patients for them.

Text (1)
Actions (2)
05/14/2020
Referred to the House Committee on Energy and Commerce.
05/14/2020
Introduced in House
Public Record
Record Updated
Jan 11, 2023 1:42:54 PM